%0 Case Reports
%T Thalidomide: An option for the pediatric patient with actinic prurigo.
%A Watts-Santos A
%A Martinez-Rico JC
%A Gomez-Flores M
%A Ocampo-Candiani J
%A Alba-Rojas E
%J Pediatr Dermatol
%V 37
%N 2
%D Mar 2020
%M 31875999
%F 1.997
%R 10.1111/pde.14086
%X Actinic prurigo (AP) is an immune-mediated photodermatosis that usually starts in childhood and is predominant among American indigenous and mestizo communities. In adults with AP, thalidomide is the treatment of choice; however, there is little information on its use in pediatric patients. We report the case of a 10-year-old girl with AP treated successfully with thalidomide.